Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||
| Net Income | -32,402 | -16,625 |
| Depreciation Amortization | 2,977 | 1,618 |
| Accounts receivable | 292 | -14 |
| Accounts payable and accrued liabilities | 1,994 | 268 |
| Other Working Capital | 4,526 | -538 |
| Other Operating Activity | 657 | -195 |
| Operating Cash Flow | $-21,956 | $-15,486 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 21,565 | -21,508 |
| PPE Investments | -5,609 | -2,168 |
| Other Investing Activity | -19 | 0 |
| Investing Cash Flow | $15,937 | $-23,676 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 4,923 | 1,468 |
| Debt Repayment | -1,192 | -802 |
| Common Stock Issued | 357 | 74 |
| Other Financing Activity | 0 | 49,881 |
| Financing Cash Flow | $4,088 | $50,621 |
| Beginning Cash Position | 18,718 | 7,259 |
| End Cash Position | 16,787 | 18,718 |
| Net Cash Flow | $-1,931 | $11,459 |
| Free Cash Flow | ||
| Operating Cash Flow | -21,956 | -15,486 |
| Capital Expenditure | -5,609 | -2,168 |
| Free Cash Flow | -27,565 | -17,654 |